Table 3.
Patient P1 |
Patient P2 |
Patient P3 |
||||||
---|---|---|---|---|---|---|---|---|
Band | Elec | dm (%) | Band | Elec | dm (%) | Band | Elec | dm (%) |
high-γ | 27 | 17.14 | high-γ | 97 | 03.40 | high-γ | 63 | 06.43 |
low-γ | 27 | 03.81 | β | 74 | 03.07 | α | 23 | 05.88 |
high-γ | 18 | 03.47 | high-γ | 83 | 02.89 | θ | 23 | 05.71 |
high-γ | 32 | 02.54 | high-γ | 67 | 02.78 | δ | 44 | 04.00 |
β | 14 | 02.38 | high-γ | 60 | 02.56 | θ | 65 | 03.29 |
α | 17 | 02.04 | high-γ | 62 | 02.13 | β | 44 | 03.17 |
low-γ | 13 | 01.98 | α | 63 | 02.09 | θ | 16 | 02.91 |
high-γ | 04 | 01.92 | high-γ | 84 | 01.93 | low-γ | 63 | 02.27 |
low-γ | 15 | 01.68 | β | 63 | 01.85 | high-γ | 69 | 01.71 |
θ | 20 | 01.47 | high-γ | 11 | 01.80 | δ | 66 | 01.67 |